Brian Sennett of the School of Medicine comments on athletes with osteoarthritis.
Perelman School of Medicine
Penn-Led International Study Finds No Difference in Nonsuicide Mortality Between Two Anti-Psychotic Drugs
PHILADELPHIA - The potential for harmful side effects associated with anti-psychotic medications for treating schizophrenia is a frustration for mental-health professionals who must balance this with the positive benefits of drugs. For example, the issue of the antipsychotic drug ziprasidone lengthening the QTc interval, a possible indicator of life-threatening heart arrhythmias, has demanded much attention among clinicians since the drug was introduced in 2001.
Gone are the days when a doctor’s only way of helping patients is by treating the disease after symptoms have started. Instead, a new approach to medicine, called “Desktop Medicine” is emerging, in which the emphasis shifts from diagnosing diseases and treating symptoms to identifying risk-factors for medical conditions such as hypertension and osteoporosis, and intervening before they develop. The commentary appears in the current issue of the Journal of the American Medical Association.
David Sarwer of the School of Medicine comments on the effect overweight people might have on their friends’ eating habits.
Yvonne Paterson of the School of Medicine is cited for the development of Advaxis’ technology.
Arthur Caplan of the School of Medicine says that physicians who have felony convictions should not be allowed to practice medicine.
Penn Scientists Identify New Role for Protein Molecule That Inhibits Response of Immune-System Cells
PHILADELPHIA -– Researchers at the University of Pennsylvania have identified a new role for a protein molecule that inhibits the response of immune-system cells to inflammatory signals associated with many human diseases.